Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey
Details
Serval ID
serval:BIB_04BADDECDBE3
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey
Journal
Journal of Comparative Neurology
ISSN
0021-9967
Publication state
Published
Issued date
06/2007
Peer-reviewed
Oui
Volume
502
Number
4
Pages
644-59
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Jun 1
Research Support, Non-U.S. Gov't --- Old month value: Jun 1
Abstract
After injury, regrowth of axons in mammalian adult central nervous system is highly limited. However, in monkeys subjected to unilateral cervical lesion (C7-C8 level), neutralization of an important neurite outgrowth inhibitor, Nogo-A, stimulated axonal sprouting caudal to the lesion, accompanied by enhanced functional recovery of manual dexterity, compared with lesioned monkeys treated with a control antibody (Freund et al. [2006] Nat. Med. 12:790-792). The present study aimed at comparing the same two groups of monkeys for axonal sprouting rostral to the cervical lesion. The corticospinal tract was labeled by injecting the anterograde tracer biotinylated dextran amine into the contralesional motor cortex. The corticospinal axons were interrupted at the level of the lesion, accompanied by retrograde axonal degeneration (axon dieback), reflected by the presence of terminal retraction bulbs. The number of terminal retraction bulbs was lower in anti-Nogo-A antibody treated monkeys, and, when present, they were found closer to the lesion than in control-antibody treated monkeys. Compared with control antibody treated monkeys, the anti-Nogo-A antibody treated monkeys exhibited an increased cumulated axon arbor length and a higher number of axon arbors going in the medial direction from the white to the gray matter. Higher in the cervical cord (at C5 level), the anti-Nogo-A treatment enhanced the number of corticospinal fibers crossing the midline, suggesting axonal sprouting. Thus, the anti-Nogo-A antibody treatment enhanced axonal sprouting rostral to the cervical lesion; some of these fibers grew around the lesion and into the caudal spinal segments. These processes paralleled the observed improved functional recovery.
Keywords
Animals
Antibodies/pharmacology/therapeutic use
Biotin/analogs & derivatives
Cell Count
Cell Size/drug effects
Dextrans
Female
Functional Laterality/physiology
Growth Cones/*drug effects/immunology/metabolism
Macaca fascicularis
Macaca mulatta
Male
Myelin Proteins/*antagonists & inhibitors/metabolism
Nerve Degeneration/drug therapy/immunology/physiopathology
Nerve Regeneration/*drug effects/immunology
Pyramidal Tracts/*drug effects/immunology/physiopathology
Recovery of Function/drug effects/immunology
Spinal Cord Injuries/*drug therapy/immunology/physiopathology
Treatment Outcome
Pubmed
Web of science
Create date
06/02/2008 10:03
Last modification date
20/08/2019 12:26